Inventor · disambiguated record
Stéphane Depil
Also filed as: DEPIL STEPHANE · DEPIL STÉPHANE · DEPIL STÉPHANE ANDRÉ
5 granted patents·8 pending applications·12 citations·filing 2006–2023
71Inventor score
Top patents by PatentIndex Score
13 records- 0187US9120791B2Indolizine compounds, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2013·Granted Sep 1, 2015·10 cites·12 claims
- 0273US9492423B2Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereofLOURY DAVID J·Filed 2011·Granted Nov 15, 2016·1 cites·9 claims
- 0370US9603854B2Indolizine compounds, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2015·Granted Mar 28, 2017·1 cites·13 claims
- 0459US2025147046A1New method for identifying herv-derived epitopesERVIMMUNE·Filed 2023·Application pending·0 cites
- 0557US2025011880A1USE OF A TRANSCRIPTOMIC SIGNATURE BASED ON HERVs EXPRESSION TO CHARACTERIZE NEW ACUTE MYELOID LEUKEMIA SUBTYPESERVIMMUNE·Filed 2022·Application pending·0 cites
- 0657US2025019771A1TRANSCRIPTOMIC SIGNATURE BASED ON HERVs EXPRESSION TO CHARACTERIZE LEUKEMIC STEM CELLS AND USEFUL AS A LSC MARKERERVIMMUNE·Filed 2022·Application pending·0 cites
- 0751US10258626B2Indolizine compounds, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2017·Granted Apr 16, 2019·0 cites·11 claims
- 0851US2015024040A1Administration regime for n-hydroxy-4-benzamideSERVIER LAB·Filed 2014·Application pending·0 cites
- 0949US2021330774A1Herv-k-derived antigens as shared tumor antigens for anti-cancer vaccineCENTRE LEON BERARD·Filed 2019·Application pending·0 cites
- 1048US2021268028A1Chimeric antigen receptors (car)-expressing cells and combination treatment for immunotherapy of patients with relapse refractory adverse genetic risk amlCELLECTIS·Filed 2019·Application pending·0 cites
- 1142US8883199B2Administration regime for N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2- ylcarbonylamino]ethoxy}benzamideKLOOS IOANA·Filed 2012·Granted Nov 11, 2014·0 cites·10 claims
- 1241US2015038513A1Association between n-hydroxy-4-benzamide and folfoxSERVIER LAB·Filed 2012·Application pending·0 cites
- 1332US2009130134A1T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereofPANCRE VERONIQUE·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stéphane Depil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →